Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Iterative Health | 2022 | Series B | $150.0M | Cambridge |
| Regor Therapeutics | 2021 | Series Unknown | $50.0M | Boston |
| DTx Pharma | 2021 | Series B | $100.0M | San Diego |
| Indianapolis Cultural Trail | 2021 | Grant | $1.0M | Indianapolis |
| Faze Medicines | 2020 | Series A | $81.0M | Cambridge |
| Sigilon Therapeutics | 2020 | Post Ipo Equity | $144.9M | Cambridge |
| Centrexion Therapeutics | 2020 | Series Unknown | $40.5M | Boston |
| Companion Medical | 2020 | Debt Financing | $27.5M | San Diego |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Iterative Health | Series B | $150.0M | Cambridge, United States |
| 102 | Regor Therapeutics | Series Unknown | $50.0M | Boston, United States |
| 103 | DTx Pharma | Series B | $100.0M | San Diego, United States |
| 104 | Indianapolis Cultural Trail | Grant | $1.0M | Indianapolis, United States |
| 105 | Faze Medicines | Series A | $81.0M | Cambridge, United States |
| 106 | Sigilon Therapeutics | Post Ipo Equity | $144.9M | Cambridge, United States |
| 107 | Centrexion Therapeutics | Series Unknown | $40.5M | Boston, United States |
| 108 | Companion Medical | Debt Financing | $27.5M | San Diego, United States |
| 109 | Rodeo Therapeutics | Series Unknown | $8.9M | Seattle, United States |
| 110 | ApoGen Biotechnologies | Series A | $4.0M | Seattle, United States |
Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.
DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.
The Indianapolis Cultural Trail is a construction entity that focuses on developing urban trails and linear parks.
Faze Medicines is a biotechnology company.
Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.
Centrexion Therapeutics is a late clinical-stage biopharmaceutical company addressing the treatment of chronic pain.
Companion Medical develops a technology designed for those living with Type 1 or Type 2 insulin-dependent diabetes.
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics.
Eli Lilly has invested in 110 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics. The firm invests across 14 different industry categories.
Among tracked funding rounds, Iterative Health received $150.0M in a Series B round. Eli Lilly's total known invested capital is $4.1B.
Eli Lilly's average investment size is $49.3M across its portfolio of 110 companies.
Recent Eli Lilly portfolio additions include Iterative Health, Regor Therapeutics, DTx Pharma, Indianapolis Cultural Trail, Faze Medicines. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors